This strategic acquisition enables CORONA Remedies to penetrate deeper into targeted specialty and offer wider accessibility
This certification paves the way for CORONA's entry into five EAEU member nations- Russia, Kyrgyzstan, Armenia, Belarus, and Kazakhstan-under a B2B business model
The company’s consolidated revenue from operations rose to Rs. 361.13 crore in Q2 FY26 and Rs. 707.67 crore for the first half
The additional production will raise the installed capacity by 400 million and available capacity by 240 million at the facility
Subscribe To Our Newsletter & Stay Updated
